Copyright
©The Author(s) 2015.
World J Pharmacol. Jun 9, 2015; 4(2): 193-209
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.193
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.193
Drug | Typical dose in younger patient (< 65 yr) | Typical dose in older patient (≥65 yr) | Reason for different dose in the elderly |
Anti-arrhythmics | |||
Digoxin | Loading dose is 1-1.5 mg in divided doses over 24 h Maintenance dose 125-250 mcg OD | Loading dose is 1 mg in divided doses over 24 h Maintenance dose 62.5-125 mcg OD | Water soluble contributing to increased plasma levels in the elderly |
Anti-coagulants | |||
Warfarin | Standard initiation dose, e.g., 10 mg daily for two days | Lower initiation dose, e.g., 5 mg daily for two days | Increased sensitivity to anticoagulant effect |
Dabigatran | 150 mg BD | Patient > 80 yr 110 mg BD Patient 75-80 yr 150 mg BD in setting or normal eGFR | Increased sensitivity to anticoagulant effect |
Anti-hypertensive | |||
Ramipril | Initiation dose 2.5 mg | Initiation dose 1.25 mg | Lower initial dose and gradual dose titration required (higher risk of ADE in the elderly) |
Psychoactive drugs | |||
Diazepam | 2 mg TDS | 1 mg BD | Lipid soluble with higher volume of distribution in older people thus contributing to a prolonged duration of effect |
- Citation: Lavan AH, O’Grady J, Gallagher PF. Appropriate prescribing in the elderly: Current perspectives. World J Pharmacol 2015; 4(2): 193-209
- URL: https://www.wjgnet.com/2220-3192/full/v4/i2/193.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i2.193